Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats.

A novel cardiac catheterization technique was devised to investigate the pulmonary arterial pressure-blood flow relationship in intact spontaneously breathing rats (ISBR) under physiological conditions with constant left atrial pressure and controlled blood flow within the normal range. Observations using this new technique in vivo were contrasted with data derived with isolated perfused rat lungs in vitro. Unlike results in in vitro isolated perfused rat lungs, the pressure-flow curves in vivo were curvilinear, with pulmonary artery pressure increasing more rapidly at low pulmonary blood flows of 4-8 ml/min and less rapidly at higher flow rates. Pressure-flow curves were reproducible and were not altered by 1-1.5 h of arrested perfusion, cyclooxygenase blockade, or perfusion with aortic or mixed venous blood. In contrast to results in in vitro isolated perfused rat lungs, N G-nitro-l-arginine methyl ester (l-NAME) increased pulmonary arterial pressure at all but the lowest flow rates with a slight effect on the curvilinear pressure-flow relationship. l-NAME reversed pulmonary vasodilator responses to acetylcholine and bradykinin and enhanced the pulmonary vasodilator response to nitroglycerin. The present data suggest that actively induced pulmonary hypertension is under greater control by endothelium-derived relaxing factor (EDRF). Unlike previous results in in vitro perfused rat lungs, results in ISBR demonstrate that the pulmonary vasodilator response to adrenomedullin-(13-52) is not mediated by calcitonin gene-related peptide receptors, which are not coupled to the release of EDRF. These results indicate that this novel technique may provide a useful model for the study of the pulmonary circulation in the intact chest rat.

[1]  S. Moncada,et al.  Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  I L Buxton,et al.  NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. , 1993, Circulation research.

[3]  D. Rodman,et al.  Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. , 1991, The American journal of physiology.

[4]  C. Pang,et al.  Effects of calcitonin gene‐related peptide receptor antagonists on renal actions of adrenomedullin , 1995, British journal of pharmacology.

[5]  J. López-Belmonte,et al.  Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation , 1989, British journal of pharmacology.

[6]  B. Walker,et al.  Role of nitric oxide in vasopressinergic pulmonary vasodilatation. , 1992, American Journal of Physiology.

[7]  M. Heymann,et al.  In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. , 1991, Journal of applied physiology.

[8]  P. Rock,et al.  N omega-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs. , 1992, The American journal of physiology.

[9]  T. McMahon,et al.  N omega-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. , 1991, Journal of applied physiology.

[10]  S. Moncada,et al.  Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. , 1990, Acta physiologica Scandinavica.

[11]  T. Evans,et al.  Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. , 1993, Journal of applied physiology.

[12]  G. Burnstock,et al.  Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat , 1995, British journal of pharmacology.

[13]  A. Hyman Effects of large increases in pulmonary blood flow on pulmonary venous pressure. , 1969, Journal of applied physiology.

[14]  S. Gardiner,et al.  Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin‐1 in conscious rats: effects of NG‐nitro‐l‐arginine methyl ester , 1990, British journal of pharmacology.

[15]  R. Ekman,et al.  CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. , 1992, The American journal of physiology.

[16]  C. Dawson,et al.  4. Pulmonary Vascular Resistance (P:Q Relations) , 1990 .

[17]  O. Griffith,et al.  L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. , 1989, Biochemical and biophysical research communications.

[18]  S. Abman,et al.  Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. , 1990, The American journal of physiology.

[19]  T. Evans,et al.  Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. , 1991, The American review of respiratory disease.

[20]  A. Cadieux,et al.  Rat adrenomedullin induces a selective arterial vasodilation via CGRP1 receptors in the double-perfused mesenteric bed of the rat. , 1995, Canadian journal of physiology and pharmacology.

[21]  J. Wallwork,et al.  Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. , 1991, The New England journal of medicine.

[22]  C. Emery,et al.  Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. , 1993, The Journal of physiology.

[23]  S. Archer,et al.  Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. , 1989, Biochemical and biophysical research communications.

[24]  L. Ignarro,et al.  Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. , 1987, Circulation research.

[25]  T. Burke-Wolin,et al.  NO and H2O2 mechanisms of guanylate cyclase activation in oxygen-dependent responses of rat pulmonary circulation. , 1995, The American journal of physiology.

[26]  S. Soifer,et al.  EDRF inhibition augments pulmonary hypertension in intact newborn lambs. , 1992, The American journal of physiology.

[27]  K. Margulies,et al.  Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. , 1991, The American journal of physiology.

[28]  C. Emery,et al.  Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats. , 1990, The European respiratory journal.

[29]  M. Heymann,et al.  N omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. , 1991, The American journal of physiology.

[30]  S. Archer,et al.  Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. , 1994, Journal of applied physiology.

[31]  T. Evans,et al.  Inhibitory role of endothelium‐derived relaxing factor in rat and human pulmonary arteries , 1990, British journal of pharmacology.

[32]  A. Kaye,et al.  Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. , 1996, The American journal of physiology.

[33]  M. Oka,et al.  EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. , 1993, The American journal of physiology.

[34]  A. Bouhuys The Pulmonary Circulation and Interstitial Space , 1970, The Yale Journal of Biology and Medicine.

[35]  S. Archer,et al.  NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. , 1992, Biochemical and biophysical research communications.

[36]  J. Stamler,et al.  Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.

[37]  P. S. Wilson,et al.  Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. , 1993, Journal of applied physiology.

[38]  K. Abromeit Music Received , 2023, Notes.

[39]  H. Lippton,et al.  Interaction of human adrenomedullin 13–52 with calcitonin gene‐related peptide receptors in the microvasculature of the rat and hamster , 1995, British journal of pharmacology.

[40]  P. Kadowitz,et al.  Pulmonary vasoconstrictor responses to graded decreases in precapillary blood PO2 in intact-chest cat. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.

[41]  A. Kaye,et al.  Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation. , 1994, European journal of pharmacology.

[42]  M. Peach,et al.  Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. , 1988, The Journal of clinical investigation.